Babban Ƙarya ta Biyar ta Nazarin Allurar Rigakafi: Bayyana Allurar Rigakafi a Matsayin "Lafiya da Inganci" a Matsayin Ajin, wata dabara ce ta yaudara, wacce ba ta da ɗabi'a wadda dole ne a kawo ƙarshenta.
Kalmomin waƙa, kalmomin kama-karya, da kuma kalmomin talla sun ƙunshi adadi mai yawa na bayanan da kafofin watsa labarai ke aika mana kowace rana. Talla ta dogara ne akan haɗa ma'anoni masu sauƙi da kyau ga duk wani samfuri da ake sayarwa.
Wani lokaci tallan da aka yi da dabara ana iya gane shi cikin sauƙi kuma yana kama da ba shi da lahani. Dangane da fifikon ku na abinci mai sauri, kuna iya yanke shawara ko dai cewa "Kai ne ke mulki"," ko kuma maimakon haka zaɓi don tabbatar da "Ina son shi"Lokacin da kake siyan mota, za ka iya gamsuwa kawai ka ce "Mu je wurare"," ko kuma za ku iya dagewa kan mallakar "Injin tuƙi na ƙarshe. "
Duk da haka, tallace-tallace, labarai, da kuma umarnin gwamnati sau da yawa suna haɗuwa - har ma suna haɗuwa - har ma da wahalar gano su. Idan jigon talla ya yi ƙarfi sosai, zai iya zama hikima ta al'ada. Wani lokaci ma ana iya ɗauka cewa gaskiya ce ta gaskiya.
Tsararrun Amurkawa sun girma suna yarda cewa "karin kumallo shine mafi mahimmancin abinci na yau." Duk da haka, wannan da'awar an fara yin sa - ba tare da wata shaida ba - a shekarar 1917 ta hannun wani babban mai sayar da hatsi na karin kumallo mai suna Kellogg Brothers. Duk da cewa wannan ikirarin game da mahimmancin karin kumallo ya fuskanci ƙalubale a cikin 'yan shekarun nan, har yanzu yana da tasiri a zukatan mutane da yawa a matsayin gaskiyar rayuwar yau da kullun.
"Lafiya da Inganci:" Taken Talla, Ba Gaskiyar Lafiya ba
Tare da fara amfani da alluran rigakafin cutar Covid, Disamba 2020, an yi wa marasa lafiya a duk duniya wani taken tallan da ba shi da tushe (kuma ba gaskiya ba ne gaba ɗaya): cewa sabbin alluran rigakafin Covid da aka samar cikin sauri "suna da aminci kuma suna da tasiri." (Idan wani ya manta da ƙarfin tallan, da fatan za a duba wannan, wannan, kuma - gulp - wannan don sabunta ƙwaƙwalwarka.)
An gaya mana cewa alluran rigakafin Covid suna da "lafiya kuma suna da tasiri." Lokaci. An maimaita wannan taken talla ba tare da iyaka ba, duk da cewa yana nufin samfura daban-daban, ta amfani da fasahohi daban-daban, duk an samar da su cikin gaggawa.
Kusan dare ɗaya, an yi hotunan Pfizer/BioNTech (fasahar mRNA), Moderna (kuma mRNA), Johnson & Johnson (fasahar vector ta ƙwayoyin cuta), AstraZeneca (kuma vector ta ƙwayoyin cuta), da Novavax (fasahar subunit ta furotin).
Ba komai ba ne. An gaya mana cewa alluran rigakafin Covid “suna da aminci kuma suna da tasiri.”
An gaya mana mu yi duk wani allurar rigakafin Covid da za a iya samu. An gaya mana cewa babu wani magani da za a iya ba ku. An gaya mana cewa hanyar da za a bi ba ta da mahimmanci. An gaya mana cewa za ku iya ma "Mix da wasa"Allunan rigakafin cutar Covid suna da "lafiya kuma suna da tasiri."
Wannan tallar ta ci gaba har zuwa yau. Kada ku damu cewa manyan alluran riga-kafi guda biyu na Covid ( Johnson & Johnson da AstraZeneca kayayyakin), dukkansu da aka yi wa lakabi da "lafiyayyu kuma masu tasiri," an cire su daga kasuwa don kashe mutane. Allurar rigakafin cutar Covid "lafiyayyu kuma masu tasiri."
Kada ku damu da cewa Tsarin Rahoton Abubuwan da suka Faru na Vaccine Adverse Event Reporting (VAERS) na CDC ya yi rajista. 38,000 mutuwar saboda alluran rigakafin Covid. Allurar rigakafin Covid “suna da aminci kuma suna da tasiri.”
Kada ku damu da ɗigon rahotannin kafofin watsa labarai da ke bayyana raguwar inganci na alluran rigakafin Covid, sakamako ne da ake iya faɗi gaba ɗaya. Wannan yana nufin cewa kuna buƙatar wani allurar ƙarawa! Allurar rigakafin Covid “suna da aminci kuma suna da tasiri.”
Domin yin bita: an cire guda biyu daga cikin hotunan Covid na asali - wadanda a da ake kira "lafiya da inganci" - daga kasuwa saboda an yi su ne da unsafeAna ci gaba da samar da sabbin nau'ikan hotunan da suka rage, saboda sigogin da suka gabata - waɗanda aka tallata a baya a matsayin masu aminci da inganci - ana samun su a kasuwa. mBugu da ƙari, mummunan tarihin tsaron da suka samu ya nuna ƙarancin karbuwar sabbin nau'ikan.
Duk da haka, alluran rigakafin Covid har yanzu suna da "lafiya kuma suna da tasiri."
An Yi Amfani da Taken "Lafiya da Inganci" Ga Duk Allurar Rigakafi
A wannan rubutun, gidan yanar gizon CDC yana da shafi wanda aka keɓe musamman don haɓaka jingle na tallan "lafiya da tasiri" don dukan alluran rigakafi. Wannan shafin yanar gizon yana da taken "Samar da Allurar Riga-kafi Masu Inganci da Inganci. "
A kirga ta, a cikin wannan takarda mai kalmomi 722, CDC ta yi amfani da kalmar "lafiya da tasiri" ko kuma ɗan ƙaramin bambanci, aƙalla sau taraCikakken kashi 3.7% na rubutun - ɗaya cikin kowace kalma 27 - maimaitawa ne na "amintacce kuma mai tasiri" na tallan "mai magana da yawun" a takaice ko kuma kusan-verbatim:
- "Ci gaba Amintacce kuma Mai inganci Magungunan rigakafi"
- "Hukumar FDA ta tsara alluran rigakafi don tabbatar da cewa an yi su daidai gwargwado" aminci da tasiri"
- "Kafin a amince da allurar riga-kafi, dole ne a shafe shekaru ana gwaji domin a tabbatar da cewa tana aiki yadda ya kamata." lafiya, tasiri, kuma fa'idodinsa sun fi haɗarin da ke tattare da shi "
- "Gwaje-gwajen asibiti sun tabbatar da cewa allurar rigakafin ta yi aiki yadda ya kamata lafiya kuma mai tasiri”
- "Haka masu bincike ke koya idan sabuwar allurar rigakafin ta kasance aminci da tasiri cikin mutane"
- "FDA ta amince da allurar idan: Yana da aminci da tasiri"
- "Mataki na 4 bincike ne da ake ci gaba da yi wanda ke duba allurar riga-kafin" aminci da tasiri"
- "ACIP ta yi nazari sosai kan dukkan bayanai game da allurar riga-kafi. Wannan ya haɗa da: aminci da tasiri na allurar rigakafin ga mutane a cikin shekaru daban-daban"
- "Tsarin tsaron allurar riga-kafi a Amurka yana tabbatar da cewa allurar riga-kafi ta kasance har yanzu" aminci da tasiri don amfani"
Wannan ba gaskiya ba ne da aka tsara don ilmantar da 'yan ƙasar Amurka. Wannan talla ce da gangan, mai amfani da dabaru, mai jan hankali, wadda gwamnati ke jagoranta. Wannan farfaganda ce.
Kada ku damu cewa an yi gaggawar kai allurar rigakafin Covid kasuwa cikin watanni (kamar yadda ake yi da allurar mura ta kowace shekara). Ku manta da "shekarun gwaji."
Kada ku damu cewa babu wani samfuri mai "haɗari" da aka yarda da shi da za a iya ɗaukarsa a matsayin "mai aminci" ba tare da wani sharaɗi ba.
Kada ku damu cewa "gwaje-gwajen asibiti" galibi ƙanana ne kuma gajeru ne don tabbatar da aminci ko inganci.
Kada ku damu cewa masu kera allurar rigakafi - waɗanda da yawa daga cikinsu suna da dogayen takardu na zamba - suna tsarawa da kuma gudanar da nasu "gwaji na asibiti."
Kada ku damu cewa "tsarin tsaron allurar riga-kafi" na CDC (VAERS) ya fuskanci hari daga ma'aikatan sa na aiki bayan sun sami mutuwar dubban mutane sakamakon harbin Covid.
Kada ku damu cewa a tarihi, an cire alluran rigakafi da dama da aka amince da su daga kasuwa saboda matsalolin tsaro da/ko inganci. misalan sun hada da:
- Allurar rigakafin mura ta alade
- Allurar riga-kafi ta Rotavirus (Rotashield)
- Allurar rigakafin shan inna ta baki
- Allurar rigakafin cutar Lyme
- Allurar rigakafin kyanda da aka kashe
- Allurar rigakafin HBV da aka samo daga jini
- Allurar rigakafin cutar Covid ta Johnson da Johnson
- Allurar riga-kafin Covid ta AstraZeneca
Zai zama abin mamaki a yi cikakken nazari kan gidajen yanar gizo na CDC, FDA, da Ma'aikatar Lafiya ta Jiha - ba tare da ambaton kayan talla na masu samar da allurar rigakafi da kuma littattafan allurar rigakafi a cikin mujallun binciken lafiya ba - don samun jimillar yawan amfani da taken "lafiya da tasiri" na farfaganda.
Hasashena shine adadin zai kai dubun-dubata.
Babban Ƙarya ta Biyar ta Nazarin Allurar Rigakafi - ayyana alluran rigakafi a matsayin marasa haɗari da tasiri a matsayin rukuni - da gangan ne, rashin gaskiya, rashin ɗa'a, kuma farfaganda ce mai kisa. Dole ne a kawo ƙarshenta.
-
CJ Baker, MD, Babban Malami na Brownstone, likita ne na cikin gida wanda ke da shekaru huɗu a fannin aikin likitanci. Ya yi naɗe-naɗen aikin likitanci da dama, kuma aikinsa ya bayyana a cikin mujallu da yawa, ciki har da Journal of the American Medical Association da New England Journal of Medicine. Daga 2012 zuwa 2018 ya kasance Farfesa na Asibiti na Humanities and Bioethics a Jami'ar Rochester.
Duba dukkan posts
